Larvol Delta - Opthea-Completes-Enrollment-in-Pivotal-Phase-3-Clinical-Program-with-Sozinibercept-in-Wet-AMD

sozinibercept (OPT-302) - Opthea

https://www.globenewswire.com/news-release/2024/05/28/2888925/0/en/Opthea-Completes-Enrollment-in-Pivotal-Phase-3-Clinical-Program-with-Sozinibercept-in-Wet-AMD.html

May 28, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next